"Insuvia", UAB
Okredo company details
Legal status
ActiveCompany ID
303249209VAT code
LT100009150711Incorporation date
24/02/2014Company's manager/representative
DONATAS GRINA, Director GeneralShare capital
2,896.00 EURActivity
Research and experimental development on biotechnologyContacts
Website
www.insuvia.com
A
HighestReliability

Fair Business loans
Borrow for business up to 50 000 € without collateralNumber of employees
31* during past year
Average wage
3,453.86 €* during past year
Debts
0.00 €* during past year
Turnover
4,303,131 €Credit report
25
Data sourcesBusiness linkages
5
LinkagesMonitoring
39
Changes during the yearSimilar companies
17
Similar companiesCompany's value
Register and
explore Okredo dataCredit limit
Estimated
"Insuvia", UAB financial ratios
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
2,274,970 |
131,501 |
674,314 |
580,011 |
33,527 |
50.52 |
25.50 |
712,390 |
150,430 |
7,402 |
834,090 |
2023 |
---|
3,487,119 |
148,831 |
1,086,869 |
930,248 |
39,703 |
51.79 |
26.68 |
1,111,988 |
278,191 |
65,317 |
1,288,659 |
2024 |
---|
4,303,131 |
146,714 |
1,125,910 |
961,666 |
32,788 |
50.17 |
22.35 |
1,073,654 |
451,103 |
282,048 |
1,233,368 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
4,303,131 €23 % *
Sales per employee (€)
146,714 €-1 % *
Profit before tax (€)
1,125,910 €4 % *
Net Profit (€)
961,666 €3 % *
Profit per employee (€)
32,788 €-17 % *
Total profitability (%)
50.17 %-3.13 % *
Net profitability (%)
22.35 %-16.23 % *
Equity (€)
1,073,654 €-3 % *
Amounts Payable And Liabilities (€)
451,103 €62 % *
Non-current Assets (€)
282,048 €332 % *
CurrentAssets (€)
1,233,368 €-4 % *
Credit history
No. of unpaid debts
Register and
explore Okredo dataAmount of unpaid debts
Register and
explore Okredo dataCredit report
Premium users: 1.00 credit
Creditor/Data source | Debt amount | Debt date | Debt type |
---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date / Payment date | Debt type |
---|---|---|---|
- | - | - | - |
Courts
Defendant
(0)
Plaintiff
(0)
3rd party
(0)
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
---|---|---|---|---|---|
- | - | - | - | - | - |
ESG data
Energy performance of the company's head office building
Energy efficiency
Vehicles
Company's eco score according CO² of vehicle fleet
Maximum environmental friendliness
Lowest environmental friendliness
Vehicles
CLASS
AMOUNT
Total
3
Eco score | Brand, model | Category | Engine capacity | Fuel |
---|---|---|---|---|
VOLVO XC40First registration: 08/03/2024 | Passenger car | - | Electricity | |
LAND ROVER RANGE ROVER SPORTFirst registration: 18/12/2024 | Passenger car | 2,996.00 cm³ | Petrol / Electricity | |
VOLVO XC90First registration: 12/09/2023 | Passenger car | 1,969.00 cm³ | Petrol / Electricity |
Trademarks
Company registered trademarks
No trademarks found
Public data
Govermental support
Institution | Support measure |
---|---|
![]() | Subsidies to preserve work places |
![]() | Non-refundable subsidy for micro-enterprises 2020 |
![]() | Fund of ILTE business stimulation means (2020) |
![]() | Covid 19 aid measures (subsidies, compensation) in 2020 - 2022 |
![]() | Covid 19 aid measures (guarantees provided) in 2020 - 2022 |
Register and
explore Okredo dataPublic negative information
Institution | Support measure |
---|---|
![]() | Redundancy of employees group (number of employees notified, date of announcement) |
![]() | Tax inspectorate information on payments in cash |
![]() | Public procurement office information on unreliable suppliers |
![]() | Public procurement office information on those that supplied false data |
![]() | Public procurement office information on possible disqualification from public procurement procedures |
Register and
explore Okredo dataPublic data
Institution | Support measure |
---|---|
![]() | Data from the B2Lithuania database of exporters |
![]() | The biggest taxpayers in 2021 |
![]() | Top taxpayers in 2021 excluding excise duties and VAT. |
![]() | Top personal income tax payers in 2021 |
![]() | Top taxpayers for corporate income tax in 2021 |
Register and
explore Okredo dataLicenses
The company has no records of any licenses', permits, certificates, or other licensing documents issued.
Public procurement
No. of won tenders
0* during past yearTotal value of contracts
0 €Number of announced tenders
0* during past yearTotal value of contracts
0 €Date | Procurer/contractor | Amount | Project |
---|---|---|---|
- | - | - | - |
Date | Procurer/contractor | Amount | Project |
---|---|---|---|
- | - | - | - |
Archive of articles
BNS News
Register and
explore Okredo dataSimilar companies
Description
About "Insuvia", UAB
"Insuvia", UAB was established in 24/02/2014, its legal status according to data of Registry of Legal Entities is Active.Main activity of the company according NACE2 classification – Research and experimental development on biotechnology, 72.11.00. Company is owned by 2 shareholders. Company's representation right – Sole representation.
In 2024 "Insuvia", UAB turnover was 4,303,131 EUR, gross profit 961,666 EUR. According to SODRA company has 31 employees. "Insuvia", UAB is registered at – Kaunas, Karaliaus Mindaugo pr. 38, LT-44307.
All data about "Insuvia", UAB is up to date and consistent with the primary data source.